Jean L. Grem

Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells.

J. Grem, V. Kao, Q. Ren, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Adjuvant 5-fluorouracil and leucovorin with or without interferon alfa-2a in colon carcinoma: National Surgical Adjuvant Breast and Bowel Project protocol C-05.

J. Bryant, N. Wolmark, J. Grem, 1998, Journal of the National Cancer Institute.

Metabolism and action of amino acid analog anti-cancer agents.

J. Grem, D. Cooney, Z. Hao, 1990, Pharmacology & therapeutics.

Mechanisms of Action and Modulation of Fluorouracil.

Grem, Jean L. Grem, 1997, Seminars in Radiation Oncology.

Mechanism of resistance to cyclopentenyl cytosine (CPE-C) in Molt-4 lymphoblasts.

J. Grem, P. Adamson, F. Balis, 1993, Biochemical pharmacology.

Pharmacodynamics and pharmacokinetics of a 72-hour infusion of 9-aminocamptothecin in adult cancer patients.

S. Arbuck, C. Takimoto, J. Grem, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Pentostatin in hairy cell leukemia: treatment by the special exception mechanism.

R. Wittes, B. Cheson, B. Leyland-Jones, 1989, Journal of the National Cancer Institute.

Doxorubicin: role in the treatment of osteosarcoma.

J. Grem, S. Blaney, M. Smith, 1993, Cancer treatment and research.